Summary
Cardinal Health, Inc. (CAH) filed an 8-K on November 16, 2009, primarily to report two significant events. First, the company announced a third amendment to its receivables purchase agreement, extending a $950 million revolving facility for an additional 364 days. This extension provides continued access to crucial financing for its operations. Second, and more strategically important for investors, the filing details the reclassification of its CareFusion segment as discontinued operations for all periods presented. This follows the spin-off of CareFusion Corporation, where Cardinal Health distributed approximately 81% of its shares. The company has also updated its reportable segments to "Pharmaceutical" and "Medical," reflecting the post-spin-off structure. This change simplifies the reporting for investors, focusing on the core continuing businesses.
Key Highlights
- 1Extension of the $950 million revolving receivables purchase facility by 364 days.
- 2CareFusion segment officially reclassified as discontinued operations.
- 3Financial reporting will reflect CareFusion's results within discontinued operations for all periods.
- 4Cardinal Health has completed the spin-off of CareFusion Corporation, distributing approximately 81% of its shares.
- 5The company has reorganized its reportable segments into two core areas: Pharmaceutical and Medical.
- 6The "Pharmaceutical" segment includes drug distribution, radiopharmaceuticals, and related services.
- 7The "Medical" segment focuses on the development, manufacturing, and distribution of medical and surgical products.